healthX Q2 FY27 revenue rose 58.8% while EBITDA loss widened
Key highlights
- healthX reported Q2 FY27 revenue from operations of Rs 489.1 crore, up 58.8% year on year.
- healthX gross-margin percentage increased to 8.3% in Q2 FY27 from 7.5% in Q2 FY26.
- healthX EBITDA loss was Rs 17.2 crore in Q2 FY27, compared with a Rs 14.9 crore loss in Q1 FY27.
- healthX has disclosed 595,000 square feet of additional planned fulfilment-centre capacity.
powered by IRIS

healthX reported Q2 FY27 revenue from operations of Rs 489.1 crore, up 58.8% year on year, and lifted gross margin to 8.3% from 7.5%, but its EBITDA loss increased to Rs 17.2 crore from Rs 14.9 crore in Q1 FY27. Higher turnover therefore did not result in positive EBITDA during the quarter.
Know Health X Platform inside out
Results, valuation, peers and who's buying, in one view.
What drove healthX’s Q2 FY27 revenue growth?
healthX’s revenue from operations rose by Rs 181.2 crore year on year to Rs 489.1 crore in Q2 FY27, and increased by Rs 48.8 crore from Rs 440.3 crore in Q1 FY27. The presentation reports growth of 58.8% against Q2 FY26 and 11.1% against the immediately preceding quarter, showing expansion on both comparison bases.
Cost of materials consumed increased to Rs 448.4 crore in Q2 FY27 from Rs 285.0 crore a year earlier and Rs 406.1 crore in Q1 FY27. That cost movement accompanied the rise in operating revenue, while the difference between sales and material costs, reported as gross margin, increased faster than revenue year on year.
For FY26, healthX recorded revenue from operations of Rs 1,305.9 crore, compared with Rs 1,088.1 crore in FY25, a stated increase of 20.0%. Q2 FY27 revenue was Rs 181.2 crore above the comparable Q2 FY26 base of Rs 307.9 crore, representing a faster growth rate than the full-year comparison.
How did healthX’s gross margin change in Q2 FY27?
healthX’s gross margin rose to Rs 40.7 crore in Q2 FY27, up 77.3% from Rs 22.9 crore in Q2 FY26 and 18.9% from Rs 34.2 crore in Q1 FY27. Gross-margin percentage reached 8.3%, compared with 7.5% a year earlier and 7.8% in the prior quarter, increases of 0.8 and 0.5 percentage points respectively.
The Q2 FY27 percentage was also above healthX’s FY26 gross-margin percentage of 7.5% and FY25 level of 6.5%. However, it remained below the 9.0% recorded in FY24, the highest annual gross-margin percentage in the five-year historical series shown in the presentation.
The gross-margin increase did not cover all operating expenses in Q2 FY27. Employee benefits expense was Rs 31.0 crore, versus Rs 27.7 crore in Q1 FY27 and Rs 19.9 crore in Q2 FY26, while other expenses were Rs 26.9 crore, compared with Rs 21.4 crore sequentially and Rs 19.1 crore a year earlier.
Why did healthX’s EBITDA loss widen despite margin expansion?
healthX’s EBITDA loss widened sequentially because its Rs 6.5 crore increase in gross margin from Q1 FY27 was less than the combined Rs 8.8 crore increase in employee benefits and other expenses. EBITDA was negative Rs 17.2 crore in Q2 FY27, compared with negative Rs 14.9 crore in Q1 FY27, although it was narrower than the negative Rs 16.0 crore recorded in Q2 FY26.
EBITDA margin was negative 3.5% in Q2 FY27, against negative 3.4% in Q1 FY27 and negative 5.2% in Q2 FY26. The comparison shows a sequential deterioration in the loss and margin, alongside a year-on-year reduction in the EBITDA loss margin, while EBITDA remained negative in all three quarters.
Below EBITDA, other income fell to Rs 5.4 crore in Q2 FY27 from Rs 19.4 crore in Q1 FY27; the presentation says other income includes financial service income. healthX moved from an EBIT profit of Rs 2.6 crore and period profit of Rs 2.0 crore in Q1 FY27 to an EBIT loss of Rs 14.4 crore and period loss of Rs 12.7 crore in Q2 FY27.
Got a follow-up? Ask IRIS
Which healthX businesses generated Q2 FY27 revenue?
healthX’s healthcare network generated Rs 484.6 crore in Q2 FY27, compared with Rs 307.9 crore in Q2 FY26 and Rs 410.7 crore in Q1 FY27. Within that network, Retailer Shakti contributed Rs 428.9 crore, while SastaSundar contributed Rs 54.9 crore and diagnostics added Rs 0.8 crore.
Retailer Shakti’s Q2 FY27 revenue was Rs 161.1 crore higher than its Rs 267.8 crore Q2 FY26 level and Rs 67.0 crore above Q1 FY27. SastaSundar increased by Rs 15.5 crore year on year from Rs 39.4 crore and by Rs 6.8 crore sequentially from Rs 48.1 crore, whereas diagnostics was Rs 0.1 crore above both comparison quarters at Rs 0.8 crore.
The vertical table reports total revenue of Rs 494.5 crore in Q2 FY27, including Rs 9.9 crore in financial services, while the consolidated profit-and-loss statement reports revenue from operations of Rs 489.1 crore. The presentation does not provide a reconciliation between these differently labelled Q2 FY27 revenue totals; financial-services revenue was Rs 49.0 crore in Q1 FY27 and negative Rs 1.1 crore in Q2 FY26.
What capacity plan has healthX disclosed?
healthX has disclosed existing warehouse capacity of about 261,800 square feet and additional planned capacity of 595,000 square feet across its fulfilment-centre network. Existing capacity includes 156,000 square feet in West Bengal, 80,000 square feet in Noida and 25,800 square feet in Guwahati.
The additional-capacity plan lists 120,000 square feet in West Bengal and 75,000 square feet in Guwahati, plus planned new fulfilment centres of 80,000 square feet each in Lucknow and Udaipur. Planned centres in Patna and Odisha are each listed at 120,000 square feet, forming the remaining 240,000 square feet of disclosed additional capacity.
The presentation says the fulfilment centres use artificial intelligence-led picking, sorting and routing, with stated aims of lower manpower cost, higher throughput and maximum delivery within 24 hours. It does not provide a commissioning date, capital-spending estimate, revenue target or EBITDA target for the 595,000 square feet of planned capacity.
Conclusion
Taken together, the quarterly data show that margin gains and higher healthcare-network revenue were accompanied by a narrower year-on-year EBITDA loss, but not by sequential operating leverage. Gross margin increased by Rs 6.5 crore from Q1 FY27 while employee benefits and other expenses increased by Rs 8.8 crore, and lower other income coincided with the move from a Q1 profit to a Q2 period loss.
The next issue to watch is execution of the disclosed 595,000 square feet of additional fulfilment-centre capacity, including new centres in Lucknow, Udaipur, Patna and Odisha. The presentation gives no rollout timetable or financial target for the additions, leaving their timing and effect on throughput and costs unresolved.


